Business
Sutro Biopharma Strengthens Leadership Through Management Promotions and Expansion of Clinical Advisory Board
SOUTH SAN FRANCISCO, Calif., March 22, 2021 /PRNewswire/ -- Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and
About this update from Sutro Biopharma, Inc.
[{"type":"text","content":"SOUTH SAN FRANCISCO, Calif., March 22, 2021 /PRNewswire/ -- Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to create next-generation cancer and autoimmune therapeutics, today announced the strengthening of key leadership roles including the promotion of David Pauling, J.D., M.A., to General Counsel, the promotion of Robert Kiss, Ph.D., to Senior Vice President, Process and Analytical Development, and the appointment of Ana Oaknin Benzaquen, M.D., Ph.D., to Sutro's Clinical Advisory Board. \nPromotion of David Pauling to General Counsel\"Sutro's ability to develop multiple programs and to collaborate with various industry partners is reflective of the sound legal guidance that David has provided over the past ten years,\" said Bill Newell, Sutro's Chief Executive Officer. \"David's astute judgement and contribution, particularly on maintaining a strong IP position on our proprietary and integrated cell-free protein synthesis platform, XpressCF®, and on the programs from the platform, have been invaluable to the growth of Sutro as an integrated biopharma company. Sutro is committed to the highest level of integrity and compliance and with David's continued legal leadership, we will continue to work diligently on bringing therapies for patients with unmet medical needs.\"\nIn his expanded role as Sutro's General Counsel, Mr. Pauling is responsible for all aspects of legal operations, including governance, compliance, disclosure, intellectual property, and agreements. Mr. Pauling joined Sutro in 2011 and has since held positions of increasing responsibility, including Intellectual Property Counsel, Associate General and Senior Intellectual Property Counsel, and most recently Executive Director of Legal Affairs. Prior to joining Sutro, Mr. Pauling practiced law at Jones Day and at Penne & Edmonds, LLP. Mr. Pauling received his J.D. from Santa Clara University School of Law (magna cum laude), and an M.A. in Molecular Biology and a B.S. in Biochemistry and Molecular Biology from the University of California, Santa Cruz.\nPromotion of Bob Kiss to SVP, Process and Analytical Development\"Since joining Sutro, Bob's leadership of the process development and analytical teams has contributed to 4 success...